Crossref
FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose
JAMA · 28.07.2026 · 336 (4) · 278
DOI: 10.1001/jama.2026.9470 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 28.07.2026. Verfasst von Samantha Anderer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Anderer, S. (2026). FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose. JAMA, 336(4), 278. https://doi.org/10.1001/jama.2026.9470
Vancouver
Anderer S. FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose. JAMA. 2026;336(4):278. doi:10.1001/jama.2026.9470
BibTeX
@article{Anderer2026,
author = {Anderer, Samantha},
title = {FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose},
journal = {JAMA},
year = {2026},
volume = {336},
number = {4},
pages = {278},
doi = {10.1001/jama.2026.9470}
}
EUVIMED